SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,795.00    100.00 (1.49%)
Bid:
6,790.00
Ask:
6,800.00
Spread: 10.00 (0.147%)
Market Cap: £5.01b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Interim Management Statement

7 Nov 2008 07:00

RNS Number : 6666H
Spirax-Sarco Engineering PLC
07 November 2008
 



Spirax-Sarco Engineering plc

Charlton House

Cheltenham

Glos. GL53 8ER

News Release

Telephone: 01242 521361

Fax: 01242 581470

www.SpiraxSarcoEngineering.com

Friday 7th November 2008 [embargoed until 7.00 am]

INTERIM MANAGEMENT STATEMENT

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam and in peristaltic pumping, issues the following Interim Management Statement based on the four month period to 31st October 2008.

Trading

As expected, we have begun to see some moderation in the pace of growth in demand from our customers, particularly in Continental Europe, although the overall organic sales growth trend in the first half year has broadly continued through October. Despite the Korean Won weakening sharply, currency effects have continued to move in our favour and have added 8% to Group revenues this year, with a larger benefit to operating profit.

Our business is today even more well spread across all geographic regions and across an even wider range of industries and products. We have a large element of replacement sales and the relatively high cost of energy has supported our energy-saving solutions for customers. These factors have historically provided some resilience.

Financial position

We continue to operate with a strong balance sheet. The Group had a net cash balance at 30th June 2008 of £12m, despite having made an initial £11m payment in February for the acquisition of Flexicon. There has been no material change in the financial position of the Group during the period, with net cash balances increasing to £26m at 31st October 2008. The company intends to purchase one million of its own shares to be held in Treasury to meet the requirements of the Group share schemes. The net liability in respect of post-retirement benefits rose to £33m (net of deferred tax) at the half-year and fluctuates in relation to movements in equity and bond markets, which remain volatile. We still expect capital expenditure to be higher than normal this year and in 2009.

Outlook

In our prospects statement in the half-year results announcement made in August, we noted the deteriorating global macro-economic environment, which has been confirmed by more recent GDP and Industrial Production rates and forecasts, and which increases the uncertainty looking forward. However, our business is well spread and generally resilient, and we have a strong balance sheet. We continue to invest for the long term, particularly in developing market areas where economic conditions look more favourable, and are focused on progressively growing our market share. Given continued beneficial exchange rates and no significant deterioration in trading conditions in our markets, we expect to achieve good progress for the year.

Enquiries:

Mark E Vernon, Chief Executive

David Meredith, Director Finance

Tel: 01242 535236

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBRBDBDGGGGIL
Date   Source Headline
1st Mar 20227:30 amRNSChange of Director Details
31st Jan 20227:00 amRNSCompletion of the acquisition of Cotopaxi
24th Jan 20227:00 amRNSAcquisition to accelerate digital strategy
17th Nov 20217:00 amRNSTrading Update
15th Nov 20211:54 pmRNSDirector/PDMR Shareholding
11th Aug 20214:46 pmRNSCorrection to Dividend Record Date in News Release
11th Aug 20217:00 amRNS2021 Half Year Results
3rd Aug 20217:00 amRNSBoard Changes
22nd Jun 20217:00 amRNSDirector/PDMR Shareholding
17th Jun 20217:00 amRNSNew Sustainability Targets Launched
4th Jun 20218:12 amRNSDirector/PDMR Shareholding
19th May 20217:00 amRNSNews Release - Investor Seminar
12th May 20214:53 pmRNSResult of AGM
12th May 20217:00 amRNSAGM TRADING UPDATE
10th May 20219:16 amRNSDirector/PDMR Shareholding
12th Apr 202111:44 amRNSDirector/PDMR Shareholding
26th Mar 20218:12 amRNSDirector/PDMR Shareholding
10th Mar 20217:00 amRNS2020 Preliminary Results
9th Mar 20218:30 amRNSBoard Appointment
7th Jan 20214:05 pmRNSDirector/PDMR Shareholding
14th Dec 202010:00 amRNSDirector/PDMR Shareholding
18th Nov 20207:00 amRNSTrading Update
9th Nov 20209:00 amRNSBoard Appointments
21st Oct 20209:21 amRNSChange of Director Details
12th Oct 20205:08 pmRNSDirector/PDMR Shareholding
12th Oct 202010:00 amRNSDirectorate Change
14th Sep 20208:00 amRNSChief Financial Officer
18th Aug 20204:19 pmRNSDirector/PDMR Shareholding
12th Aug 20207:00 amRNS2020 Half Year Results
6th Aug 20208:00 amRNSAdditional Listing
28th Jul 202012:24 pmRNSSection 430(2b) Companies Act - Nimesh Patel
23rd Jul 20207:30 amRNSChange of Director Details
22nd Jun 20203:39 pmRNSChange of Director Details
22nd Jun 20202:45 pmRNSDirector/PDMR Shareholding
20th May 20209:00 amRNSChange of Director Details
13th May 20204:32 pmRNSResult of AGM
13th May 20207:00 amRNSAGM Statement - Trading Update
28th Apr 202011:30 amRNSDisclosure of Rights attached to Equity Shares
24th Apr 20208:59 amRNSAGM Alternative Arrangements
8th Apr 202010:33 amRNSSection 430(2B) Companies Act 2006 Statement
3rd Apr 202011:14 amRNSDirector/PDMR Shareholding
2nd Apr 20208:00 amRNSSpirax Sarco appoints next Chief Financial Officer
30th Mar 20208:30 amRNSChange of Director Details
13th Mar 20209:48 amRNSDirector/PDMR Shareholding
12th Mar 202012:00 pmRNSDirector/PDMR Shareholding
11th Mar 20207:05 amRNSBoard Change
11th Mar 20207:00 amRNS2019 Preliminary Results
7th Feb 20205:35 pmRNSDirector Declaration
13th Nov 20197:00 amRNSTrading Update
10th Sep 20193:30 pmRNSChange of Director Details

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.